Human isolated bronchial smooth muscle contains functional ryanodine/caffeine-sensitive Ca-release channels.
Human bronchial smooth muscle (HBSM) contraction is implicated in a variety of respiratory diseases, including asthma. Yet, the presence of an operative calcium-induced calcium release (CICR) mechanism, identified in various smooth muscles, has not been established in HBSM. We therefore studied Ca-releasing mechanisms in HBSM obtained at thoracotomy with special attention to ryanodine-sensitive receptor channels (RyRs). In freshly isolated bronchial myocytes, ryanodine (0.5 to 50 microM) and caffeine (1 to 25 mM) induced transient increases in the cytoplasmic calcium concentration ([Ca(2+)](i)). Higher ryanodine concentrations (> 100 microM) inhibited the caffeine-induced [Ca(2+)](i) response, which was also blocked in the presence of tetracaine (300 microM) or ruthenium red (200 microM), two potent CICR inhibitors. In HBSM strips, caffeine induced a transient contraction which, likewise, was inhibited by ryanodine and tetracaine. However, ryanodine (200 microM) modified neither the [Ca(2+)](i) response nor the contraction induced by K(+)-rich (110 mM) solution. Reverse transcriptase/polymerase chain reaction (RT-PCR) and RNase protection assay performed in HBSM have revealed the existence of mRNAs encoding only the type 3 RyR. We also characterized acetylcholine-induced [Ca(2+)](i) and contractile responses. None of these responses was altered by ryanodine or by tetracaine. These results demonstrate, for the first time, the existence of functional RyRs in HBSM cells which, owing to the type of isoform or the amount of protein expressed, are not involved, under physiologic conditions, in depolarization- or agonist-induced contraction.
Laboratoire de Physiologie Cellulaire Respiratoire INSERM (E 9937), Université Bordeaux 2, Bordeaux, France.
J M
JM
Hyvelin
C
C
Martin
E
E
Roux
R
R
Marthan
J P
JP
Savineau
D000109:Acetylcholine / Q000494:pharmacology; D000328:Adult; D000368:Aged; D001980:Bronchi / Q000378:metabolism*; D002110:Caffeine / Q000494:pharmacology*; D015220:Calcium Channels / Q000032:analysis* / Q000187:drug effects / Q000235:genetics; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000502:physiology; D009130:Muscle, Smooth / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D012430:Ruthenium Red / Q000494:pharmacology; D012433:Ryanodine / Q000494:pharmacology*; D013748:Tetracaine / Q000494:pharmacology
D015220:Calcium Channels; D012333:RNA, Messenger; D013748:Tetracaine; D012430:Ruthenium Red; D012433:Ryanodine; D002110:Caffeine; D000109:Acetylcholine